Gastric adenocarcinoma under the age of 40; more metastatic, less differentiated

Isik M., Caner S., Metin Seker M., Civelek B., Odabas H., Ozdemir N., ...More

Journal of B.U.ON., vol.16, no.2, pp.253-256, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 2
  • Publication Date: 2011
  • Journal Name: Journal of B.U.ON.
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.253-256
  • Keywords: age under 40, differentiation, gastric adenocarcinoma, metastasis, CANCER, CARCINOMA, STOMACH, YOUNGER
  • Lokman Hekim University Affiliated: No


Purpose: Gastric carcinoma is relatively rare under the age of 40 years, and the mean age at presentation is 65 years. Histologically, adenocarcinoma prevails. Previous studies state that gastric adenocarcinoma under 40 is more aggressive. The present retrospective study was undertaken to clarify the clinicopathological characteristics of gastric adenocarcinoma inpatients under 40 and to compare their clinical features with the patients over 40 years of age. Methods: All of the patients with histologically diagnosed gastric adenocarcinoma who had applied to our department from March 2001 to September 2009 were retrospectively evaluated. Patients were stratified according to their age at diagnosis (≤ 40 years; group 1, and > 40 years; group 2). Their clinical, laboratory, and pathological characteristics were analyzed. Results: 251 patients were studied. Sixty-eight percent of those under 40 and 46% over 40 had poorly differentiated histology (p= 0.036). Fifteen (60%) patients under 40 and 73 (32.3%) over 40 had metastatic diseases (p=0.007). Conclusion: Younger patients with gastric adenocarcinoma have less differentiated, more advanced and metastatic disease. Patients' complaints, tumor localization, metastatic sites and smoking did not differ significantly between the groups. Controversy for survival parameters still exists. © 2011 Zerbinis Medical Publications.